Current Issue

Click here to read the latest interactive issue >

march12cover

 

  

 

Click here to view back issues

Follow us on twitter
surgeonsnews: Trauma care - getting the right fit for Scotland http://t.co/e8dQV7aA
Renal tumours and the robot
Friday, 01 October 2010

Mottrie A, De Naeyer G, Schatteman P, et al. Impact of the learning  curve on perioperative outcome in patients who underwent robotic partial  nephrectomy for parenchymal tumours. Eur Urol 2010; 58: 127-33.

 

In a nutshell


This is a single centre trial  evaluating the learning curve for  Robotic Partial Nephrectomy (RAPN)  over a three-year period. Sixty-two  consecutive patients underwent  transperitoneal RAPN for  parenchymal renal tumours using  the da Vinci Surgical System. Data  were collected prospectively and  included perioperative outcomes  such as operative times and warm  ischaemia times (WIT), blood loss,  overall complications and renal  function impairment. Prior to  surgery, patients had either a  magnetic resonance imaging scan  or a 3D computed tomography scan  to define clinical stage, anatomical  characteristics of the tumour and the  presence of any accessory vessels. 

The surgery was carried out by a  single surgeon with considerable  experience in robotic surgery and a  background of having performed 15  laparoscopic partial nephectomies  before the study began. The mean  tumour size was 2.8 +/- 1.3cm.  Histologic subtypes were angiomyolipoma  (8.1%), oncocytoma (14.5%),  clear cell renal cell carcinoma (RCC)  (50%), papillary RCC (21%) and  chromophobe RCC (6.5%). The  median console time was 90 minutes  (interquartile range: 63-116). Mean  warm ischaemia time (WIT) was 20  +/- 7 mins (range: 9-40) and overall  perioperative complications were  reported in 16.1% of cases. WIT  (<20 mins) and console times were  optimised after the first 30 cases  (p<0.001). Pathologic stage was  pT1a in (89.6%), pT1b (10.4%) and  there was a positive surgical margin  rate of 2%. The postoperative  creatinine value was slightly higher  in comparison with the mean  baseline value (p<0.01).

Second opinion

This is a small trial evaluating an initial experience of RAPN in the hands of an experienced robotic surgeon. The authors admit that it was difficult to identify ideal parameters and criteria to evaluate the initial experience with this new surgical procedure. The conclusions of the study were that RAPN requires a short learning curve to reach WIT <20 minutes, console times <100 minutes, limited blood loss, and acceptable overall complication rates. These results are impressive and contrast with laparoscopic partial nephrectomy (LPN), which is considered a technically challenging procedure. LPN requires a long learning curve in order to reach an acceptable perioperative complication rate and WIT.

It is a non-randomised single centre study with a limited number of patients, and is probably not applicable to centres with much less experience in robotic surgery. RAPN is also expensive and this will limit its use. However, a randomised prospective study comparing LPN with RAPN would prove most useful.

The verdict

  • Nephron-sparing surgery is currently the ‘gold standard’ for treatment of renal tumours ?4cm.
  • RAPN can be considered the natural evolution and simplification of traditional LPN
  • RAPN is a viable option for nephron sparing surgery in patients with renal cell carcinoma.
  • RAPN requires a short learning curve to reach WIT <20mins, console times <100mins and acceptable overall complication rates.


John P O’Donoghue
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Jeremy P Crew
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Comments (0)Add Comment

Write comment
smaller | bigger

busy
 

readersurvey_sky

Follow us on twitter
surgeonsnews: Trauma care - getting the right fit for Scotland http://t.co/e8dQV7aA

 twitter      facebook

sky1

Follow us on twitter
surgeonsnews: Trauma care - getting the right fit for Scotland http://t.co/e8dQV7aA